Reassessment colonoscopy to diagnose serrated polyposis syndrome in a colorectal cancer screening population
Liseth Rivero-Sanchez,Maria Lopez-Ceron,Sabela Carballal,Leticia Moreira,Xavier Bessa,Anna Serradesanferm,Angels Pozo,Josep Maria Augé,Teresa Ocaña,Ariadna Sánchez,María Liz Leoz,Míriam Cuatrecasas,Jaume Grau,Josep Llach,Antoni Castells,Francesc Balaguer,Maria Pellisé,Josep Augé,María Leoz,
DOI: https://doi.org/10.1055/s-0042-115640
2016-10-14
Endoscopy
Abstract:<b>Background and study aims</b> Serrated polyposis syndrome (SPS) is a high risk condition for colorectal cancer (CRC). Surveillance strategies for patients with serrated lesions remain controversial. We aimed to evaluate a diagnostic strategy to detect SPS consistently during reassessment colonoscopy in patients with proximal serrated lesions. <b>Methods</b> This was a retrospective study of all individuals from a fecal immunochemical test (FIT)-based CRC screening program (2010 - 2013) with one or more serrated lesions of ≥ 5 mm proximal to the sigmoid colon on baseline colonoscopy. We analyzed all individuals empirically scheduled for a reassessment colonoscopy aimed at diagnosing SPS within 1 year. Reassessment colonoscopy was performed with standard white-light or chromoendoscopy ± high definition endoscopy depending on availability. SPS diagnosis was based on the cumulative number of polyps in both the baseline and reassessment colonoscopies. Factors associated with SPS diagnosis were analyzed. <b>Results </b>From 3444 screening colonoscopies, 196 patients met the study entry criteria, of whom 11 patients (0.32 %) met the criteria for SPS on baseline colonoscopy. Reassessment colonoscopies were performed in 71 patients at 11.9 ± 1.7 months and detected 20 additional patients with SPS, a tripling of the rate of SPS up to 0.90 %. Independent factors associated with SPS diagnosis were: having five or more proximal serrated lesions (odds ratio [OR] 4.01 [95 % confidence interval 1.20 - 13.45]; <i>P = </i>0.02) or two or more sessile serrated polyps ≥ 10 mm (OR 6.35 [1.40 - 28.81]; <i>P = </i>0.02) on baseline colonoscopy and the use of chromoendoscopy ± high definition endoscopy during reassessment colonoscopy (OR 4.99 [1.11 - 22.36]; <i>P = </i>0.04). <b>Conclusions </b>A 1-year reassessment colonoscopy using chromoendoscopy and high definition endoscopes substantially improves SPS detection in individuals from a FIT-based screening program with proximal serrated lesions. Five or more proximal serrated lesions or two or more sessile serrated polyps ≥ 10 mm could be thresholds for requiring a reassessment colonoscopy. Prospective studies are required to validate these results and adjust surveillance recommendations in patients with serrated lesions.
gastroenterology & hepatology,surgery